Clinical trial

Clinical Characteristics and Outcomes of Coronary Heart Disease: a Prospective Cohort Study

Name

xx20190901

Description

This study evaluated and compared the prognostic value of different Baseline data and clinical variables to develop a risk ractor ediction model in patients with CHD.

Trial arms

Trial start

2020-02-01

Estimated PCD

2022-01-31

Trial end

2022-04-30

Status

Completed

Treatment

Drug:Standard therapy

Percutaneous coronary Intervention

Arms:

Size

20000

Primary endpoint

Death （All-cause mortality、Cardiac mortality ）

5 years of follow-up deaths occurred during this period

Eligibility criteria

Inclusion Criteria 1. Patients diagnosed with Coronary Heart Disease (CHD) admitted to The First Affiliated Hospital of Xinjiang Medical University. The diagnosis is based on clinical assessments, including symptomatic evaluation, electrocardiographic findings, and coronary imaging studies. Exclusion Criteria 1. Patients who have experienced a Myocardial Infarction (MI) within the last month. 2. Patients who have undergone coronary revascularization, such as coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI), in the last three months. 3. Patients with a pre-planned coronary revascularization procedure.

Protocol

{'studyType': 'OBSERVATIONAL', 'patientRegistry': False, 'designInfo': {'observationalModel': 'COHORT', 'timePerspective': 'PROSPECTIVE'}, 'enrollmentInfo': {'count': 20000, 'type': 'ACTUAL'}}

Updated at

2024-03-29

1 organization

1 product

1 indication

Organization

Xinjiang Medical University

Product

Standard therapy

Indication

Coronary Heart Disease